A new era begins in risk communication regarding drug use in pregnancy: Changes in FDA pregnancy risk categories
Türkiye Aile Hekimliği Dergisi · 2014
DOI: 10.15511/tahd.14.04195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Türkiye Aile Hekimliği Dergisi, 2014. Verfasst von Yusuf Cem Kaplan. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Twenty nine years after the introduction of Pregnancy Risk Categories, U.S. Food and Drug Administration (FDA) concluded that categories were not successful at conveying the possible risks of drug use in pregnancy. FDA announced its second generation approach to labeling drugs for use in pregnancy and lactation with the publication of Proposed Rule for Pregnancy and Lactation Labeling for Human Prescription Drug and Biological Products on May 29, 2008. The proposed rule is designed as a narrative text containing elements such as fetal risk summary, clinical considerations and data. This manuscript aims to increase information and awareness of family practitioners on this subject.
Zitieren
APA
Kaplan, Y. C. (2014). A new era begins in risk communication regarding drug use in pregnancy: Changes in FDA pregnancy risk categories. Türkiye Aile Hekimliği Dergisi. https://doi.org/10.15511/tahd.14.04195
Vancouver
Kaplan YC. A new era begins in risk communication regarding drug use in pregnancy: Changes in FDA pregnancy risk categories. Türkiye Aile Hekimliği Dergisi. 2014. doi:10.15511/tahd.14.04195
BibTeX
@article{Kaplan2014,
author = {Kaplan, Yusuf Cem},
title = {A new era begins in risk communication regarding drug use in pregnancy: Changes in FDA pregnancy risk categories},
journal = {Türkiye Aile Hekimliği Dergisi},
year = {2014},
doi = {10.15511/tahd.14.04195}
}
EUVIMED